Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diazoxide Dose Response in Obese Men
NCT00151684Phase 2Completed
- Sponsor
- Rijnstate
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of diazoxide in obesity, sponsored by Rijnstate. Primary endpoints: Body Weight, Abdominal Circumference and 2 more. Started Nov 2004; status: completed.
02
Drugs
diazoxide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00151684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151684.